Saturday, July 11, 2026

pharma · Encephalitis · Japanese Encephalitis

Valneva USA

Valneva USA clinical programs — 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Bethesda, USA HQ
2017 Founded
9 Employees
EMA registrant Type
Company details
Status
Public
HQ
Bethesda, USA
Founded
2017
Employees
9
Programs
2
Drugs
1
Patents
0
Intelligence · Clinical Programs

Valneva USA projects

2 ClinicalTrials.gov programs sponsored by Valneva USA.

Valneva USA has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. IC51

    Valneva Austria GmbH

    Encephalitis

    phase 3 mab completed

    1 trial
  2. IXIARO

    Valneva Austria GmbH

    Japanese Encephalitis

    phase 3 mab completed

    1 trial

Frequently asked questions

How many clinical projects does Valneva USA have?

2 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.